The Need for a Mycoses Reporting System
In recent years, human fungal infections have taken on a new dimension. Many fungi that previously were considered normal flora, colonists, or environmental saprobes now threaten the lives of individuals, particularly those individuals with underlying debilitating diseases. These compromised individuals, when infected by any systemic fungal pathogen, are likely to develop disseminated disease. The rapidity of invasiveness of some of the opportunists, the paucity of effective, nontoxic antifungal drugs, and the lack of vaccines are serious challenges to the health of a growing segment of the population. These individuals and communities suffering from serious systemic or opportunistic mycoses impact immediately on health care systems. The extent of this impact, nationally, is largely unknown due to the lack of a national mycoses reporting system.
KeywordsHuman Immunodeficiency Virus Antifungal Drug Systemic Mycosis Public Health Laboratory Opportunistic Mycosis
Unable to display preview. Download preview PDF.
- 4.Harrell ER, Honeycutt WM. Coccidioidomycosis: A traveling fungus disease.Arch. Dermatol. 87: 188–196, 1983.Google Scholar
- 6.CDC. Revision of the CDC Surveillance case definition for acquired immunodeficiency syndrome. MMWR 36 (no. S1): 1–9, 1987.Google Scholar
- 7.National Committee for Clinical Laboratory Standards . 1985. Antifungal susceptibility testing; Committee Report. NCCLS publication M20-CR. Villanova, PA: NCCLS.Google Scholar